STRO Sutro Biopharma, Inc. - Common Stock
$22.16
मूल्य · अग 18, 2026
मौलिकता इस प्रकार है अग 12, 2026
52W रेंज
$1–$44
50% of range
विश्लेषक रेटिंग
BUY
19 analysts
मूल्य लक्ष्य
$48
+116% upside
P/E (TTM)
-1.0
ROE
232.2%
शुद्ध लाभ मार्जिन
-186.5%
Sutro Biopharma, Inc. - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell, CEO as of 2024, joined Sutro in January 2009.
और पढ़ें
Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell, CEO as of 2024, joined Sutro in January 2009.
Sutro's cell-free protein synthesis and site-specific conjugation platform, XpressCF+, contributed to the discovery of STRO-001 and STRO-002, internally-developed antibody drug conjugates, or ADCs. STRO-001 is an ADC targeting CD74, a protein highly expressed in multiple myeloma and non-Hodgkin's lymphoma, and is currently in a Phase I clinical trial. STRO-002 is an ADC targeting folate receptor alpha, a cell-surface protein highly expressed in gynecological cancers.
As of 2024 Sutro's drug discovery efforts have focused on antibody-drug conjugates, cytokine-based immuno-oncology therapies, and bispecific antibodies primarily directed at clinically validated targets for which the current standard of care is suboptimal.
Technology
Sutro's Xpress CF Platform is based on Stanford Professor James R. Swartz's patented Open Cell-Free Synthesis (OCFS) technology. XpressCF technology enables the parallel expression of hundreds of protein variants in less than 24 hours, providing a platform for the discovery and development of a wide variety of protein classes including cytokines, vaccine carrier-proteins, antibodies, and novel antibody-based proteins. The XpressCF+ platform allows for precise incorporation of non-natural amino acids into a protein sequence, and Sutro is using this technology to develop homogeneous site-specific antibody-drug conjugates (ADCs). Once identified, production of protein drug candidates can be scaled in Sutro's cGMP manufacturing facility located in San Carlos, CA.
Sutro's technology has also contributed to the formation of SutroVax, a vaccine spin off founded in 2015 that has raised over US$170 million in capital.
Collaborations
In July 2018, Sutro signed a collaboration and licensing agreement with Merck to discover and develop novel cytokine-based therapies for cancer and autoimmune disorders. Sutro received an upfront payment of $60 million and is eligible for milestone payments totaling up to $1.6 billion associated with the development and sale of all therapeutic candidates and all possible indications identified under the collaboration. In 2017, Sutro and Celgene announced they had refocused their 2014 immuno-oncology collaboration on four programs advancing through preclinical development, including an ADC program targeting B-Cell maturation antigen (BCMA).
Awards
The XpressCF Platform was awarded Best ADC Technology Platform at the World ADC in 2018, with Sutro as the runner up for Best New Drug Developer. Sutro was named one of Fierce Biotech's Fierce 15 in 2014. In 2015 was awarded the DiNA Outstanding Partner Award by the California Life Sciences Association.
== References ==
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
STRO स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$22.16
मार्केट कैप
$190M
P/E (TTM)
-1.0
EPS (TTM)
$-22.49
राजस्व (TTM)
$102M
लाभांश प्रतिफल
—
ROE
232.2%
D/E ऋण/इक्विटी
—
52W रेंज
$1 – $44
STRO स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
Configure
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व और शुद्ध आय
$102M
2016-12-31
→
2025-12-31
EPS
$-22.49
2020-12-31
→
2025-12-31
फ्री कैश फ्लो
—
2018-12-31
→
2018-12-31
मार्जिन
-186.5%
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
मेट्रिक
5Y रुझान
STRO
सहकर्मी माध्यिका
P/E (TTM)
-1.0
6.1
P/S (TTM)
1.9
7.7
P/B
-1.4
2.2
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
मेट्रिक
5Y रुझान
STRO
सहकर्मी माध्यिका
Operating Margin (परिचालन मार्जिन)
-154.5%
—
Net Profit Margin (शुद्ध लाभ मार्जिन)
-186.5%
-60.9%
ROA
-68.1%
-50.0%
ROE
232.2%
-44.8%
ROIC
119.5%
—
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
मेट्रिक
5Y रुझान
STRO
सहकर्मी माध्यिका
Current Ratio (वर्तमान अनुपात)
2.0
5.9
Quick Ratio (त्वरित अनुपात)
1.9
—
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
मेट्रिक
5Y रुझान
STRO
सहकर्मी माध्यिका
Revenue YoY (राजस्व YoY)
65.2%
—
Revenue CAGR 3Y (राजस्व CAGR 3Y)
14.8%
—
Revenue CAGR 5Y (राजस्व CAGR 5Y)
19.1%
—
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
मेट्रिक
5Y रुझान
STRO
सहकर्मी माध्यिका
STRO विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
खरीदें
19 विश्लेषक
- मजबूत खरीद 5 26.3%
- खरीदें 12 63.2%
- होल्ड 1 5.3%
- बेचें 1 5.3%
- मजबूत बिक्री 0 0.0%
12-महीने का मूल्य लक्ष्य
13 विश्लेषक · 2026-08-13
मध्यिका
$50.00
अभी
$22.16
निम्न
$10.00
उच्च
$61.00
मध्यिका लक्ष्य
$50.00
+125.6%
माध्य लक्ष्य
$47.77
+115.6%
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
-0.34%
| Period | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|
| 31 मार्च 2026 | $-2.94 | $-3.85 | 0.91% |
| 31 दिसमबर 2025 | $-5.29 | $-4.43 | -0.86% |
| 30 सितमबर 2025 | $-6.70 | $-4.23 | -2.5% |
| 30 जून 2025 | $-1.40 | $-4.10 | 2.7% |
| 31 मार्च 2025 | $-9.10 | $-7.22 | -1.9% |
| 31 दिसमबर 2024 | $-8.90 | $-8.48 | -0.42% |
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| STRO | $99M | -0.5 | 65.2% | -186.5% | 232.2% | — |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | — |
| DMAC | $428M | — | — | — | -78.7% | — |
| GALT | $271M | -8.7 | — | — | 25.0% | — |
| ZNTL | $93M | -0.7 | — | — | -49.5% | — |
| IPSC | $87M | -7.1 | 1556.8% | -8.8% | -5.2% | — |
| SABS | — | — | — | — | — | — |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | — |
| IMRX | — | -5.2 | — | — | -45.3% | — |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण 15
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $102M | $62M | $154M | $68M | $62M | $43M | $43M | $38M | $52M | |
| R&D Expense | $166M | $252M | $180M | $137M | $104M | $77M | $66M | $54M | $55M | |
| SG&A Expense | $41M | $48M | $63M | $60M | $56M | $37M | $33M | $21M | $16M | |
| Operating Expenses | $261M | $300M | $243M | $197M | $160M | $114M | $98M | $76M | $71M | |
| Operating Income | $-158M | $-238M | $-89M | $-129M | $-99M | $-71M | $-55M | $-37M | $-19M | |
| Interest Expense | · | · | · | · | · | · | · | $2M | $612.0K | |
| Other Non-op | · | · | · | · | · | · | · | $2M | $-77.0K | |
| Pretax Income | $-191M | $-225M | $-89M | $-117M | $-106M | $-32M | · | · | · | |
| Income Tax | $-93.0K | $2M | $18M | $2M | $0 | $103.0K | $0 | $0 | $0 | |
| Net Income | $-191M | $-227M | $-107M | $-119M | $-106M | $-32M | $-119M | $-35M | $-20M | |
| EPS (Basic) | $-22.49 | $-29.40 | $-1.78 | $-2.35 | $-2.29 | $-0.99 | · | · | · | |
| EPS (Diluted) | $-22.49 | $-29.40 | $-1.78 | $-2.35 | $-2.29 | $-0.99 | · | · | · | |
| Shares (Basic) | 8,497,798 | 7,736,734 | 60,163,542 | 50,739,185 | 46,119,089 | 32,573,469 | · | · | · | |
| Shares (Diluted) | 8,497,798 | 7,736,734 | 60,163,542 | 50,739,185 | 46,119,089 | 32,573,469 | · | · | · | |
| EBITDA | $-151M | $-231M | $-82M | $-123M | $-94M | $-67M | · | $-33M | · |
बैलेंस शीट 24
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $58M | $190M | $69M | $47M | $30M | $206M | $5M | $125M | $22M | |
| Short-term Investments | $83M | $127M | $264M | $255M | $130M | $120M | $113M | $79M | · | |
| Receivables | $4M | $9M | $36M | $7M | $12M | $6M | $6M | $2M | $2M | |
| Prepaid Expense | $6M | $18M | $10M | $12M | $8M | $4M | $4M | $3M | $2M | |
| Current Assets | $151M | $343M | $422M | $353M | $219M | $378M | $129M | $210M | $26M | |
| PP&E (Net) | $11M | $18M | $22M | $25M | $23M | $13M | $10M | $11M | $14M | |
| PP&E (Gross) | $38M | $67M | $64M | $63M | $56M | $50M | $43M | $40M | $39M | |
| Accum. Depreciation | $27M | $49M | $42M | $38M | $33M | $37M | $34M | $29M | $25M | |
| Other Non-current Assets | $495.0K | $7M | $4M | $2M | $2M | $2M | $3M | $2M | $1M | |
| Total Assets | $174M | $387M | $471M | $407M | $341M | $394M | $156M | $223M | $41M | |
| Accounts Payable | $8M | $10M | $9M | $5M | $6M | $6M | $6M | $3M | $3M | |
| Accrued Liabilities | $15M | $13M | $15M | $13M | $11M | $9M | $6M | $6M | $4M | |
| Current Liabilities | $75M | $132M | $94M | $67M | $42M | $30M | $33M | $36M | $32M | |
| Capital Leases | $8M | $16M | $23M | $30M | $31M | · | · | · | · | |
| Other Non-current Liabilities | $2M | $2M | $2M | $119.0K | $146.0K | $481.0K | $134.0K | $102.0K | $14.0K | |
| Total Liabilities | $306M | $343M | $321M | $190M | $89M | $62M | $59M | $92M | $47M | |
| Long-term Debt | · | · | $4M | $16M | $25M | $25M | · | $15M | · | |
| Total Debt | · | · | $4M | $16M | $25M | $25M | · | $10M | · | |
| Common Stock | $9.0K | $8.0K | $61.0K | $58.0K | $46.0K | $46.0K | $23.0K | $23.0K | · | |
| Retained Earnings | $-978M | $-787M | $-559M | $-453M | $-333M | $-228M | $-196M | $-150M | $-115M | |
| AOCI | $19.0K | $39.0K | $21.0K | $-618.0K | $-314.0K | $129.0K | $165.0K | $-47.0K | · | |
| Stockholders' Equity | $-132M | $45M | $150M | $217M | $253M | $332M | $98M | $132M | $-109M | |
| Liabilities + Equity | $174M | $387M | $471M | $407M | $341M | $394M | $156M | $223M | $41M | |
| Shares Outstanding | 8,584,309 | 8,306,398 | 61,009,829 | 57,499,541 | 46,327,131 | 45,752,116 | 23,098,969 | 22,848,184 | 465,330 |
नकदी प्रवाह 16
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $7M | $7M | $6M | $5M | $4M | $5M | $5M | $5M | |
| Stock-based Comp | $14M | $25M | $25M | $26M | $23M | $12M | $10M | $3M | $1M | |
| Restructuring | $13M | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-7M | $4M | $-37M | $91M | $-4M | $-52M | · | $41M | · | |
| Operating Cash Flow | $-177M | $-192M | $-112M | $4M | $-82M | $-68M | $-65M | $13M | $-37M | |
| CapEx | · | · | · | · | · | · | · | $2M | $3M | |
| Investing Cash Flow | $45M | $219M | $-4M | $-35M | $-97M | $604.0K | $-51M | $-80M | $33M | |
| Debt Issued | · | · | · | · | · | · | · | $0 | $15M | |
| Net Debt Issued | · | · | · | · | · | · | · | $0 | · | |
| Stock Issued | $0 | $25M | $0 | $0 | · | $251M | $-327.0K | · | · | |
| Stock Repurchased | · | · | · | · | $7.0K | · | · | · | · | |
| Net Stock Activity | $0 | $25M | $12M | $56M | $-7.0K | $251M | · | · | · | |
| Financing Cash Flow | $44.0K | $94M | $138M | $48M | $3M | $269M | $-4M | $171M | $15M | |
| Net Change in Cash | $-132M | $121M | $22M | $17M | $-176M | $202M | $-120M | $103M | $10M | |
| Taxes Paid | $75.0K | $18M | $379.0K | $0 | $103.0K | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | · | $11M | · |
लाभप्रदता 7
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -154.5% | -384.3% | -58.1% | -190.3% | -159.2% | -166.3% | · | -96.9% | · | |
| Net Margin | -186.5% | -366.6% | -69.5% | -175.9% | -170.6% | -75.2% | · | -91.9% | · | |
| Pretax Margin | -186.5% | -362.8% | -57.6% | -172.2% | · | · | · | · | · | |
| EBITDA Margin | -147.4% | -372.7% | -53.6% | -181.9% | -151.4% | -156.3% | · | -85.1% | · | |
| ROA | -68.1% | -53.0% | -24.3% | -31.9% | -28.7% | -11.7% | · | -26.8% | · | |
| ROE | 232.2% | -292.0% | -81.5% | -53.4% | -39.4% | -11.2% | · | 713.8% | · | |
| ROIC | 119.5% | -540.2% | -70.0% | -56.5% | · | · | · | · | · |
तरलता और शोधन क्षमता 5
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.6 | 4.5 | 5.3 | 5.2 | 12.8 | · | 5.8 | · | |
| Quick Ratio | 1.9 | 2.5 | 3.9 | 4.7 | 4.2 | 11.2 | · | 5.7 | · | |
| Debt / Equity | · | · | 0.0 | 0.1 | 0.1 | 0.1 | · | 0.1 | · | |
| LT Debt / Equity | · | · | 0.0 | 0.0 | 0.1 | 0.1 | · | 0.1 | · | |
| Interest Coverage | · | · | · | · | · | · | · | -22.9 | · |
दक्षता 2
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.1 | 0.4 | 0.2 | 0.2 | 0.2 | · | 0.3 | · | |
| Receivables Turnover | 16.3 | 2.8 | 7.1 | 6.9 | 6.9 | 7.2 | · | 18.7 | · |
विकास दरें 3
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 65.2% | -59.6% | 126.8% | 9.5% | 44.8% | · | · | · | · | |
| Revenue CAGR 3Y | 14.8% | 0.09% | 53.2% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.1% | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM) 14
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $102M | $62M | $154M | $68M | $62M | $43M | $43M | $38M | · | |
| Net Income TTM | $-191M | $-227M | $-107M | $-119M | $-106M | $-32M | $-119M | $-35M | · | |
| Market Cap | $99M | $152M | $262M | $465M | $689M | $993M | · | $206M | · | |
| Enterprise Value | · | · | $-68M | $179M | $554M | $691M | · | $12M | · | |
| P/E | -0.5 | -0.1 | -2.4 | -3.4 | -6.5 | -21.9 | · | · | · | |
| P/S | 1.0 | 2.4 | 1.7 | 6.9 | 11.1 | 23.2 | · | 5.4 | · | |
| P/B | -0.7 | 3.4 | 1.7 | 2.1 | 2.7 | 3.0 | · | 1.6 | · | |
| P / Tangible Book | · | 3.4 | 1.7 | 2.1 | 2.7 | 3.0 | · | · | · | |
| P / Cash Flow | -0.6 | -0.8 | -2.3 | 130.9 | -8.4 | -14.6 | · | 16.2 | · | |
| P / FCF | · | · | · | · | · | · | · | 18.5 | · | |
| EV / EBITDA | · | · | 0.8 | -1.4 | -5.9 | -10.4 | · | -0.4 | · | |
| EV / FCF | · | · | · | · | · | · | · | 1.0 | · | |
| EV / Revenue | · | · | -0.4 | 2.6 | 8.9 | 16.2 | · | 0.3 | · | |
| Earnings Yield | -194.4% | -1597.8% | -41.5% | -29.1% | -15.4% | -4.6% | · | · | · |
आय विवरण 13
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | $15M | $12M | $10M | $64M | $17M | $15M | $9M | $26M | $13M | $114M | $17M | $10M | $13M | $9M | $25M | |
| R&D Expense | $32M | $37M | $37M | $40M | $38M | $52M | $71M | $62M | $62M | $57M | $54M | $46M | $42M | $39M | $43M | $32M | |
| SG&A Expense | $8M | $8M | $9M | $9M | $10M | $13M | $9M | $14M | $12M | $13M | $17M | $15M | $15M | $16M | $15M | $15M | |
| Operating Expenses | $40M | $44M | $50M | $58M | $67M | $86M | $80M | $76M | $74M | $70M | $71M | $61M | $57M | $55M | $58M | $46M | |
| Operating Income | $-30M | $-30M | $-38M | $-48M | $-3M | $-69M | $-65M | $-68M | $-49M | $-57M | $43M | $-44M | $-46M | $-42M | $-49M | $-21M | |
| Pretax Income | $-39M | $-38M | $-47M | $-57M | $-12M | $-76M | $-70M | $-49M | $-48M | $-58M | $47M | $-47M | $-38M | $-50M | $-35M | $-19M | |
| Income Tax | $1.0K | $-15.0K | $-82.0K | $0 | $-18.0K | $7.0K | $2M | $0 | $8.0K | · | $16M | $2M | $151.0K | $395.0K | $0 | $0 | |
| Net Income | $-39M | $-38M | $-47M | $-57M | $-11M | $-76M | $-72M | $-49M | $-48M | $-58M | $31M | $-49M | $-39M | $-50M | $-35M | $-19M | |
| EPS (Basic) | $-2.33 | $-2.94 | $-20.77 | $-0.67 | $-1.35 | $-9.08 | $-27.63 | $-0.59 | $-0.59 | $-0.59 | $0.52 | $-0.81 | $-0.64 | $-0.85 | $-0.59 | $-0.37 | |
| EPS (Diluted) | $-2.33 | $-2.94 | $-20.77 | $-0.67 | $-1.35 | $-9.08 | $-27.63 | $-0.59 | $-0.59 | $-0.59 | $0.52 | $-0.81 | $-0.64 | $-0.85 | $-0.59 | $-0.37 | |
| Shares (Basic) | 16,571,602 | 13,082,355 | -244,058,204 | 84,869,864 | 8,511,985 | 8,364,294 | -216,989,358 | 82,043,671 | 81,224,628 | 61,457,793 | -119,498,390 | 60,599,025 | 60,339,475 | 58,723,432 | -95,063,345 | 52,345,732 | |
| Shares (Diluted) | 16,571,602 | 13,082,355 | -244,058,204 | 84,869,864 | 8,511,985 | 8,364,294 | -216,989,358 | 82,043,671 | 81,224,628 | 61,457,793 | -119,498,390 | 60,599,025 | 60,339,475 | 58,723,432 | -95,063,345 | 52,345,732 | |
| EBITDA | $-30M | $-28M | · | $-48M | $-3M | $-67M | · | $-68M | $-49M | $-55M | · | $-44M | $-46M | $-41M | · | $-21M |
बैलेंस शीट 23
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $74M | $58M | $66M | $64M | $106M | $190M | $175M | $91M | $65M | $69M | $82M | $235M | $62M | $47M | $97M | |
| Short-term Investments | $110M | $129M | $83M | $102M | $141M | $143M | $127M | $214M | $285M | $202M | $264M | $239M | $123M | $189M | · | $191M | |
| Receivables | $6M | $12M | $4M | $4M | $8M | $14M | $9M | $7M | $7M | $31M | $36M | $17M | $10M | $10M | · | $11M | |
| Prepaid Expense | $6M | $6M | $6M | $11M | $18M | $25M | $18M | $11M | $11M | $10M | $10M | $9M | $10M | $18M | · | $11M | |
| Current Assets | $176M | $221M | $151M | $182M | $232M | $287M | $343M | $406M | $443M | $355M | $422M | $381M | $412M | $304M | · | $347M | |
| PP&E (Net) | $8M | $9M | $11M | $13M | $15M | $17M | $18M | $19M | $19M | $21M | $22M | $22M | $24M | $24M | · | $24M | |
| PP&E (Gross) | · | · | $38M | · | · | · | $67M | · | · | · | $64M | · | · | · | · | · | |
| Accum. Depreciation | · | · | $27M | · | · | · | $49M | · | · | · | $42M | · | · | · | · | · | |
| Other Non-current Assets | $1M | $1M | $495.0K | $0 | $50.0K | $85.0K | $7M | $7M | $5M | $6M | $4M | $3M | $3M | $3M | · | $2M | |
| Total Assets | $194M | $242M | $174M | $210M | $262M | $321M | $387M | $452M | $489M | $403M | $471M | $432M | $465M | $358M | · | $401M | |
| Accounts Payable | $3M | $5M | $8M | $7M | $4M | $8M | $10M | $6M | $6M | $8M | $9M | $6M | $4M | $5M | · | $12M | |
| Accrued Liabilities | $6M | $5M | $15M | $13M | $12M | $12M | $13M | $13M | $10M | $7M | $15M | $11M | $10M | $6M | · | $10M | |
| Current Liabilities | $53M | $71M | $75M | $72M | $74M | $133M | $132M | $131M | $130M | $80M | $94M | $74M | $67M | $59M | · | $58M | |
| Capital Leases | $4M | $6M | $8M | $10M | $12M | $14M | $16M | $18M | $20M | $21M | $23M | $25M | $27M | $28M | · | $31M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | · | $133.0K | |
| Total Liabilities | $298M | $309M | $306M | $297M | $294M | $347M | $343M | $341M | $337M | $305M | $321M | $319M | $310M | $173M | · | $171M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $7M | |
| Common Stock | $17.0K | $17.0K | $9.0K | $85.0K | $85.0K | $84.0K | $8.0K | $82.0K | $82.0K | $62.0K | $61.0K | $61.0K | $60.0K | $60.0K | · | $55.0K | |
| Retained Earnings | $-1.05B | $-1.02B | $-978M | $-931M | $-874M | $-863M | $-787M | $-714M | $-666M | $-618M | $-559M | $-590M | $-541M | $-503M | · | $-418M | |
| AOCI | $-58.0K | $-101.0K | $19.0K | $33.0K | $-13.0K | $-9.0K | $39.0K | $106.0K | $-163.0K | $-113.0K | $21.0K | $7.0K | $16.0K | $-107.0K | · | $-1M | |
| Stockholders' Equity | $-103M | $-67M | $-132M | $-87M | $-32M | $-26M | $45M | $111M | $152M | $98M | $150M | $112M | $155M | $185M | $217M | $230M | |
| Liabilities + Equity | $194M | $242M | $174M | $210M | $262M | $321M | $387M | $452M | $489M | $403M | $471M | $432M | $465M | $358M | · | $401M | |
| Shares Outstanding | 16,576,205 | 16,566,803 | 8,584,309 | 85,101,749 | 84,720,047 | 84,349,041 | 8,306,398 | 82,395,350 | 81,861,584 | 62,456,546 | 61,009,829 | 60,900,704 | 60,471,041 | 60,161,801 | · | 54,631,360 |
नकदी प्रवाह 10
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $5M | $6M | $6M | $7M | $6M | $6M | $6M | $6M | $7M | $6M | $6M | $7M | |
| Restructuring | · | $0 | $1M | $3M | $1M | $8M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-7M | · | · | · | $647.0K | · | · | · | $-14M | · | · | · | $-19M | · | · | |
| Operating Cash Flow | $-38M | $-42M | $-26M | $-38M | $-45M | $-68M | $-72M | $-65M | $9M | $-65M | $14M | $-34M | $-31M | $-61M | $-24M | $66M | |
| Investing Cash Flow | $19M | $-45M | $19M | $40M | $3M | $-16M | $87M | $147M | $-80M | $64M | $-24M | $-114M | $66M | $67M | $-38M | $-78M | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-418.0K | $103M | $-64.0K | $102.0K | $-60.0K | $66.0K | $-24.0K | $1M | $96M | $-3M | $-3M | $-6M | $138M | $9M | $12M | $30M | |
| Net Change in Cash | $-19M | $16M | $-8M | $2M | $-42M | $-84M | $16M | $84M | $26M | $-4M | $-13M | $-153M | $173M | $15M | $-50M | $18M | |
| Taxes Paid | $1.0K | $-15.0K | $64.0K | $0 | $4.0K | $7.0K | $2M | $2.0K | $15M | $10.0K | · | · | · | · | · | · |
लाभप्रदता 7
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -303.8% | -204.2% | · | -499.9% | -5.2% | -393.8% | · | -797.2% | -189.4% | -435.1% | · | -260.1% | -443.5% | -333.3% | · | -84.3% | |
| Net Margin | -391.6% | -265.0% | · | -586.6% | -18.0% | -436.6% | · | -572.6% | -186.8% | -447.5% | · | -291.2% | -370.0% | -394.9% | · | -77.5% | |
| Pretax Margin | -391.6% | -265.1% | · | -586.6% | -18.1% | · | · | -572.6% | -186.8% | -447.5% | · | -280.3% | -368.6% | -391.8% | · | -77.5% | |
| EBITDA Margin | -303.8% | -195.4% | · | -499.9% | -5.2% | -382.9% | · | -797.2% | -189.4% | -421.5% | · | -260.1% | -443.5% | -320.5% | · | -84.3% | |
| ROA | -16.9% | -13.7% | · | -17.2% | -3.1% | -21.0% | · | -11.0% | -10.1% | -15.3% | · | -11.8% | -9.1% | -15.1% | · | -5.1% | |
| ROE | 56.9% | 83.0% | · | -474.8% | -19.1% | -210.4% | · | -43.6% | -31.3% | -41.1% | · | -28.8% | -21.2% | -24.7% | · | -7.6% | |
| ROIC | 28.9% | 44.3% | · | 55.5% | 10.4% | · | · | -61.1% | -32.0% | · | · | -40.7% | -30.0% | -23.0% | · | · |
तरलता और शोधन क्षमता 4
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 3.1 | · | 2.5 | 3.1 | 2.2 | · | 3.1 | 3.4 | 4.5 | · | 5.2 | 6.1 | 5.1 | · | 5.9 | |
| Quick Ratio | 3.2 | 3.0 | · | 2.4 | 2.9 | 2.0 | · | 3.0 | 2.9 | 3.8 | · | 4.6 | 5.5 | 4.4 | · | 5.1 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
दक्षता 2
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | · | 0.0 | 0.2 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | 1.4 | 1.1 | · | 1.8 | 8.5 | 0.8 | · | 0.7 | 3.0 | 0.6 | · | 1.2 | 0.2 | 1.2 | · | 2.1 |
मूल्यांकन (TTM) 12
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $98M | $105M | · | $99M | $115M | $65M | · | $64M | $66M | $53M | · | $65M | $76M | $72M | · | $68M | |
| Net Income TTM | $-145M | $-183M | · | $-193M | $-184M | $-231M | · | $-204M | $-194M | $-196M | · | $-157M | $-134M | $-135M | · | $-116M | |
| Market Cap | $550M | $413M | · | $74M | $60M | $55M | · | $285M | $240M | $353M | · | $211M | $281M | $278M | · | $303M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $23M | |
| P/E | -4.6 | -1.9 | · | -0.4 | -0.3 | -0.2 | · | -1.3 | -1.1 | -2.0 | · | -1.3 | -1.9 | -1.8 | · | -2.3 | |
| P/S | 5.6 | 3.9 | · | 0.7 | 0.5 | 0.8 | · | 4.4 | 3.6 | 6.7 | · | 3.2 | 3.7 | 3.9 | · | 4.5 | |
| P/B | -5.3 | -6.2 | · | -0.8 | -1.9 | -2.1 | · | 2.6 | 1.6 | 3.6 | · | 1.9 | 1.8 | 1.5 | · | 1.3 | |
| P / Tangible Book | · | · | · | · | · | · | · | 2.6 | 1.6 | 3.6 | · | 1.9 | 1.8 | 1.5 | · | 1.3 | |
| P / Cash Flow | · | -9.8 | · | · | · | -0.8 | · | · | · | -5.5 | · | · | · | -4.6 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -1.1 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.3 | |
| Earnings Yield | -22.0% | -51.5% | · | -265.5% | -314.1% | -412.3% | · | -74.6% | -89.8% | -51.1% | · | -77.0% | -51.8% | -56.5% | · | -43.8% |
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
आय विवरण
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| राजस्व | $102M | $62M | $154M | $68M | $62M |
| परिचालन मार्जिन % | -154.5% | -384.3% | -58.1% | -190.3% | -159.2% |
| शुद्ध आय | $-191M | $-227M | $-107M | $-119M | $-106M |
| तनुकरणित EPS | $-22.49 | $-29.40 | $-1.78 | $-2.35 | $-2.29 |
बैलेंस शीट
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| ऋण / इक्विटी | — | — | 0.0 | 0.1 | 0.1 |
| वर्तमान अनुपात | 2.0 | 2.6 | 4.5 | 5.3 | 5.2 |
| त्वरित अनुपात | 1.9 | 2.5 | 3.9 | 4.7 | 4.2 |
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
📊
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
संस्थागत मालिक (13F) 111 फाइलर्स · $467.3M कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 46 (+21 पिछली तिमाही की तुलना में) | 16 (+8 पिछली तिमाही की तुलना में) | 20 (0 पिछली तिमाही की तुलना में) | 19 (+5 पिछली तिमाही की तुलना में) | +1.3M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | $43320887 | 1304846 | 9.27% | शेयर |
| BVF INC/IL | $41559362 | 1251788 | 8.89% | शेयर |
| Affinity Asset Advisors, LLC | $38926568 | 1172487 | 8.33% | शेयर |
| SAMSARA BIOCAPITAL, LLC | $35287350 | 1062872 | 7.55% | शेयर |
| Kynam Capital Management, LP | $28968926 | 872558 | 6.20% | शेयर |
| ORBIMED ADVISORS LLC | $24698941 | 743944 | 5.29% | शेयर |
| Balyasny Asset Management L.P. | $23610578 | 711162 | 5.05% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $23048071 | 694219 | 4.93% | शेयर |
| EVENTIDE ASSET MANAGEMENT, LLC | $19430698 | 585262 | 4.16% | शेयर |
| Velan Capital Investment Management LP | $17003712 | 512160 | 3.64% | शेयर |
| Woodline Partners LP | $15206563 | 458029 | 3.25% | शेयर |
| ADAR1 Capital Management, LLC | $13413265 | 404014 | 2.87% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $12150270 | 365972 | 2.60% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $11027500 | 332057 | 2.36% | शेयर |
| STATE STREET CORP | $10158503 | 305979 | 2.17% | शेयर |
| Merck & Co., Inc. | $9042053 | 272351 | 1.93% | शेयर |
| ACUTA CAPITAL PARTNERS, LLC | $8972333 | 270251 | 1.92% | शेयर |
| AMERIPRISE FINANCIAL INC | $8123011 | 244669 | 1.74% | शेयर |
| Point72 Asset Management, L.P. | $7895856 | 237827 | 1.69% | शेयर |
| KVP Capital Advisors, LP | $7522290 | 226575 | 1.61% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $6696042 | 201688 | 1.43% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6559058 | 197562 | 1.40% | शेयर |
| UBS Group AG | $5407251 | 162869 | 1.16% | शेयर |
| Seven Fleet Capital Management LP | $3794182 | 159118 | 0.81% | शेयर |
| Qube Research & Technologies Ltd | $3539452 | 106610 | 0.76% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $3460502 | 104232 | 0.74% | शेयर |
| CITADEL ADVISORS LLC | $3385205 | 101964 | 0.72% | शेयर |
| MACKENZIE FINANCIAL CORP | $3146264 | 94767 | 0.67% | शेयर |
| RENAISSANCE TECHNOLOGIES LLC | $2865957 | 86324 | 0.61% | शेयर |
| MARSHALL WACE, LLP | $2448865 | 73761 | 0.52% | शेयर |
| Y-Intercept (Hong Kong) Ltd | $1855183 | 55879 | 0.40% | शेयर |
| Squarepoint Ops LLC | $1843895 | 55539 | 0.39% | शेयर |
| XTX Topco Ltd | $1732011 | 52169 | 0.37% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1636826 | 49302 | 0.35% | शेयर |
| Sigma Planning Corp | $1494664 | 45020 | 0.32% | शेयर |
| Fisher Asset Management, LLC | $1171794 | 35295 | 0.25% | शेयर |
| Elmind Capital, LP | $1063628 | 32037 | 0.23% | शेयर |
| D. E. Shaw & Co., Inc. | $1000250 | 30128 | 0.21% | शेयर |
| GOLDMAN SACHS GROUP INC | $975814 | 29392 | 0.21% | शेयर |
| Trexquant Investment LP | $917515 | 27636 | 0.20% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $909116 | 27383 | 0.19% | शेयर |
| BANK OF AMERICA CORP /DE/ | $863897 | 26021 | 0.18% | शेयर |
| RHUMBLINE ADVISERS | $684845 | 20628 | 0.15% | शेयर |
| JPMORGAN CHASE & CO | $625079 | 18743 | 0.13% | शेयर |
| BlackRock, Inc. | $595276 | 17930 | 0.13% | शेयर |
| SEI INVESTMENTS CO | $544048 | 16387 | 0.12% | शेयर |
| Informed Momentum Co LLC | $538902 | 16232 | 0.12% | शेयर |
| DEUTSCHE BANK AG\ | $516692 | 15563 | 0.11% | शेयर |
| RBF Capital, LLC | $507030 | 15272 | 0.11% | शेयर |
| WELLS FARGO & COMPANY/MN | $449661 | 13544 | 0.10% | शेयर |
| AJU IB Investment Co., Ltd. | $435925 | 17500 | 0.09% | शेयर |
| Bank of New York Mellon Corp | $434522 | 13088 | 0.09% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $368520 | 11100 | 0.08% | कॉल ऑप्शन |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $365200 | 11000 | 0.08% | पुट ऑप्शन |
| MetLife Investment Management, LLC | $312113 | 9401 | 0.07% | शेयर |
| Walleye Capital LLC | $308959 | 9306 | 0.07% | शेयर |
| Integrated Quantitative Investments LLC | $296775 | 8939 | 0.06% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $279743 | 8426 | 0.06% | शेयर |
| Lighthouse Investment Partners, LLC | $277818 | 8368 | 0.06% | शेयर |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $242792 | 7313 | 0.05% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $242360 | 7300 | 0.05% | शेयर |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $232433 | 7001 | 0.05% | शेयर |
| Persistent Asset Partners Ltd | $218091 | 6569 | 0.05% | शेयर |
| CITIGROUP INC | $216995 | 6536 | 0.05% | शेयर |
| Verdad Advisers, LP | $212480 | 6400 | 0.05% | शेयर |
| Invesco Ltd. | $211119 | 6359 | 0.05% | शेयर |
| HSBC HOLDINGS PLC | $205722 | 6234 | 0.04% | शेयर |
| TWO SIGMA ADVISERS, LP | $203401 | 17580 | 0.04% | शेयर |
| NEW YORK STATE COMMON RETIREMENT FUND | $185920 | 5600 | 0.04% | शेयर |
| MORGAN STANLEY | $181870 | 5478 | 0.04% | शेयर |
| Vanguard Global Advisers, LLC | $180774 | 5445 | 0.04% | शेयर |
| Police & Firemen's Retirement System of New Jersey | $156173 | 4704 | 0.03% | शेयर |
| Nuveen, LLC | $131837 | 3971 | 0.03% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $119520 | 3600 | 0.03% | शेयर |
| Nuveen Asset Management, LLC | $103678 | 56347 | 0.02% | शेयर |
| BARCLAYS PLC | $84228 | 2537 | 0.02% | शेयर |
| NORTHERN TRUST CORP | $83100 | 2503 | 0.02% | शेयर |
| State of Wyoming | $53718 | 1618 | 0.01% | शेयर |
| Legal & General Group Plc | $51394 | 1548 | 0.01% | शेयर |
| Ameritas Investment Partners, Inc. | $48074 | 1448 | 0.01% | शेयर |
| FMR LLC | $44388 | 1337 | 0.01% | शेयर |
| Russell Investments Group, Ltd. | $42330 | 1275 | 0.01% | शेयर |
| VANGUARD GROUP INC | $36307 | 3138 | 0.01% | शेयर |
| Tower Research Capital LLC (TRC) | $28751 | 866 | 0.01% | शेयर |
| Point72 Asia (Singapore) Pte. Ltd. | $26943 | 31026 | 0.01% | शेयर |
| CWM, LLC | $24487 | 983 | 0.01% | शेयर |
| ROYAL BANK OF CANADA | $23000 | 687 | 0.00% | शेयर |
| Owl Creek Wealth Partners LLC | $16302 | 491 | 0.00% | शेयर |
| ACADIAN ASSET MANAGEMENT LLC | $12405 | 373839 | 0.00% | शेयर |
| Sterling Capital Management LLC | $9329 | 281 | 0.00% | शेयर |
| Quantbot Technologies LP | $6673 | 201 | 0.00% | शेयर |
| Physician Wealth Advisors, Inc. | $6043 | 182 | 0.00% | शेयर |
| MERCER GLOBAL ADVISORS INC /ADV | $3718 | 112 | 0.00% | शेयर |
| OSAIC HOLDINGS, INC. | $3320 | 100 | 0.00% | शेयर |
| PNC Financial Services Group, Inc. | $2058 | 62 | 0.00% | शेयर |
| Fortitude Family Office, LLC | $1859 | 56 | 0.00% | शेयर |
| Bogart Wealth, LLC | $1660 | 50 | 0.00% | शेयर |
| Parallel Advisors, LLC | $1560 | 47 | 0.00% | शेयर |
| NISA INVESTMENT ADVISORS, LLC | $1461 | 44 | 0.00% | शेयर |
| Accredited Wealth Management, LLC | $869 | 5 | 0.00% | शेयर |
कंपनी के अंदरूनी सूत्र 27 इनसाइडर्स · 14 अधिकारी · 14 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| William J Newell | CEO | 3 मार्च 2023 M | 164816 | 0 | 0 | $0 |
| Gregory K. Chow | CFO | 2 जून 2026 M | 4725 | 0 | 0 | $0 |
| Edward C Albini | CFO and Secretary | 3 मार्च 2023 M | 87693 | 0 | 0 | $0 |
| Jane Chung | President and COO | 1 दिसमबर 2023 A | 31698 | 0 | 0 | $0 |
| Hans-Peter Gerber | Chief Scientific Officer | 18 सितमबर 2023 A | — | 0 | 0 | $0 |
| Brunilda Shtylla | Chief Business Officer | 28 अगस्त 2023 S | 0 | 0 | 0 | $0 |
| Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | 12 जुलाई 2023 M | 24988 | 0 | 0 | $0 |
| Venkatesh Srinivasan | Chief Tech Op Officer | 1 मई 2023 A | — | 0 | 0 | $0 |
| Trevor Hallam | Pres. Rsrch & Cf. Sctific Ofcr | 14 अप्रैल 2023 M | 100368 | 0 | 0 | $0 |
| Anne Elizabeth Borgman | Chief Medical Officer | 15 मार्च 2023 A | — | 0 | 0 | $0 |
| Anik Shabbir | Chief Technical Ops. Officer | 3 मार्च 2023 M | 40827 | 0 | 0 | $0 |
| Linda A Fitzpatrick | Chief People & Comm. Officer | 3 मार्च 2023 M | 52690 | 0 | 0 | $0 |
| Arturo Molina MD | Chief Medical Officer | 5 मार्च 2022 M | 37736 | 0 | 0 | $0 |
| Stephen Worsley | Chief Business Officer | 29 जनवरी 2019 A | — | 0 | 0 | $0 |
| Heidi Hunter | निदेशक | 5 जून 2026 A | — | 0 | 0 | $0 |
| Michael Dybbs | निदेशक | 5 जून 2026 A | — | 0 | 0 | $0 |
| Jon Marc Wigginton | निदेशक | 5 जून 2026 A | — | 0 | 0 | $0 |
| Sukhi Jagpal | निदेशक | 5 जून 2026 A | — | 0 | 0 | $0 |
| Joseph M Lobacki | निदेशक | 5 जून 2026 A | — | 0 | 0 | $0 |
| Daniel H Petree | निदेशक | 5 जून 2026 A | 18601 | 0 | 0 | $0 |
| Connie Matsui | निदेशक | 5 जून 2026 A | 50000 | 1 | 0 | $40000 |
| James P Panek | निदेशक | 5 जून 2026 A | — | 0 | 0 | $0 |
| John Gordon Freund | निदेशक | 8 जून 2023 A | 56327 | 0 | 0 | $0 |
| Shalini Sharp | निदेशक | 6 जून 2022 A | — | 0 | 0 | $0 |
| Daniel Janney | निदेशक | 17 जून 2019 A | 1944901 | 0 | 0 | $0 |
| Michael Jay Ross | निदेशक | 1 अक्टूबर 2018 C | 18248 | 0 | 0 | $0 |
| Bryan V Lawlis | निदेशक | 26 सितमबर 2018 A | — | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
कार्यकर्ता और 5%+ मालिक 1 होल्डिंग
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| SVLSF V, LLC, SV Life Sciences Fund V, L.P., SV Life Sciences Fund V Strategic Partners, L.P., SV Life Sciences Fund V (GP), L.P., ILSF III, LLC, International Life Sciences Fund III (GP), L.P., International Life Sciences Fund III Co-Investment, L.P., International Life Sciences Fund III (LP1), L.P., International Life Sciences Fund III Strategic Partners, L.P. | 9 अक्टूबर 2018 | — | प्रारंभिक फाइलिंग | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ईटीएफ स्वामित्व 15 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.43% | 3826 SH | 8 अगस्त 2026 | दैनिक |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.25% | 28745 SH | 8 अगस्त 2026 | दैनिक |
| IWC · iShares Trust | 0.09% | 54216 SH | 8 अगस्त 2026 | दैनिक |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 11715 SH | 8 अगस्त 2026 | दैनिक |
| IWN · iShares Trust | 0.02% | 121308 SH | 8 अगस्त 2026 | दैनिक |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 91894 SH | 8 अगस्त 2026 | दैनिक |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 16520 SH | 8 अगस्त 2026 | दैनिक |
| IWM · iShares Trust | 0.01% | 398610 SH | 8 अगस्त 2026 | दैनिक |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 177152 SH | 8 अगस्त 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.01% | 47358 SH | 8 अगस्त 2026 | दैनिक |
| IWO · iShares Trust | 0.00% | 22665 SH | 8 अगस्त 2026 | दैनिक |
| ITOT · iShares Trust | 0.00% | 29451 SH | 8 अगस्त 2026 | दैनिक |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 501524 SH | 8 अगस्त 2026 | दैनिक |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2670 SH | 8 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1330 SH | 8 अगस्त 2026 | दैनिक |